PT  - JOURNAL ARTICLE
AU  - Menon, D Girijanandan
AU  - George, Manjit
AU  - Salim, Salih V
AU  - Sreekumar, R.
AU  - Philip, Sam
AU  - Mathew, Roshin K
AU  - Bju, Princymol
AU  - Mathai, Merin Helen
TI  - Splitting ratio in sevoflurane vapouriser-a relook on calculations
AID  - 10.1101/2024.04.11.24305499
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.11.24305499
4099  - http://medrxiv.org/content/early/2024/04/12/2024.04.11.24305499.short
4100  - http://medrxiv.org/content/early/2024/04/12/2024.04.11.24305499.full
AB  - Textbooks of anaesthesia describe in detail the calculations associated with splitting ratios created in variable bypass vapourisers. These calculations are based on assumptions of carrier gas flow (eg:assume 150 ml) as practised with measured flow vaporizers[1,2]. Carrier gas flow in a variable bypass vaporizer is agent specific,dynamic,unknown and operator independent.Therefore assuming carrier gas flow in calculations related to variable bypass vaporisers is without rationale[3]. In spite of technological advance,the amount of vapour produced is calculated based on clinically impractical assumptions. A simple method and formula is suggested for the quick estimate of vapour output, carrier gas flow and determine the splitting ratio while operating a sevoflurane variable bypass vaporizer.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript